These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9708834)

  • 1. Attention deficit/hyperactivity disorder--from brain dysfunctions to behaviour.
    Sagvolden T; Sergeant JA
    Behav Brain Res; 1998 Jul; 94(1):1-10. PubMed ID: 9708834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
    Fone KC; Nutt DJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infrequent, but not frequent, reinforcers produce more variable responding and deficient sustained attention in young children with attention-deficit/hyperactivity disorder (ADHD).
    Aase H; Sagvolden T
    J Child Psychol Psychiatry; 2006 May; 47(5):457-71. PubMed ID: 16671929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered reinforcement mechanisms in attention-deficit/hyperactivity disorder.
    Sagvolden T; Aase H; Zeiner P; Berger D
    Behav Brain Res; 1998 Jul; 94(1):61-71. PubMed ID: 9708840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
    Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes.
    Sagvolden T; Johansen EB; Aase H; Russell VA
    Behav Brain Sci; 2005 Jun; 28(3):397-419; discussion 419-68. PubMed ID: 16209748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of NSS in ADHD.
    Pasini A; D'agati E
    World J Biol Psychiatry; 2009; 10(4 Pt 2):495-502. PubMed ID: 19337883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurological basis of attention deficit hyperactivity disorder.
    Ballard S; Bolan M; Burton M; Snyder S; Pasterczyk-Seabolt C; Martin D
    Adolescence; 1997; 32(128):855-62. PubMed ID: 9426808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder.
    O'Driscoll GA; Dépatie L; Holahan AL; Savion-Lemieux T; Barr RG; Jolicoeur C; Douglas VI
    Biol Psychiatry; 2005 Jun; 57(11):1452-60. PubMed ID: 15950020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The diagnostic evaluation and therapeutic basis of immediate release methylphenidate in attention deficit hyperactivity disorder].
    Valdizán JR
    Rev Neurol; 2004 Mar 16-31; 38(6):501-6. PubMed ID: 15054710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impulsiveness as a timing disturbance: neurocognitive abnormalities in attention-deficit hyperactivity disorder during temporal processes and normalization with methylphenidate.
    Rubia K; Halari R; Christakou A; Taylor E
    Philos Trans R Soc Lond B Biol Sci; 2009 Jul; 364(1525):1919-31. PubMed ID: 19487194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention deficit/hyperactivity disorder in adults.
    Moss SB; Nair R; Vallarino A; Wang S
    Prim Care; 2007 Sep; 34(3):445-73, v. PubMed ID: 17868755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobiology of ADHD.
    Tripp G; Wickens JR
    Neuropharmacology; 2009 Dec; 57(7-8):579-89. PubMed ID: 19627998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relationship between attention deficit hyperactivity disorder and sleep-alertness problems].
    Golan N; Pillar G
    Harefuah; 2004 Sep; 143(9):676-80, 693. PubMed ID: 15521685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.